The effectiveness of the antimalarial drug hydroxychloroquine for the treatment of coronavirus has not been confirmed by large studies. This was announced by the director of the WHO health emergency program Michael Ryan on July 29.
Ryan noted that although there was some benefit in the small, observational studies, all the large studies did not show any benefit with hydroxychloroquine.
Ryan said there is ample medical evidence to support the scientific evidence that hydroxychloroquine “did not improve the condition of patients with confirmed coronavirus.”
Ineffectiveness against COVID-19 was also confirmed by the chief infectious disease specialist of the United States, Dr. Anthony Fauci, the BBC reported on July 29. The Food and Drug Administration (FDA) of the US Department of Health and Human Services has warned against using the drug in the treatment of coronavirus infection.
Hydroxychloroquine is an anti-malaria drug that has been used in some countries to treat coronavirus patients.
In June, the World Health Organization (WHO) decided to stop trials of hydroxychloroquine as a drug against coronavirus.
The spread of the SARS-CoV-2 coronavirus, which causes the COVID-19 disease, began last December in the Chinese city of Wuhan. On March 11, the World Health Organization declared a pandemic.